Potlako: A Programmatic Intervention to Improve Access to Timely Oncology Care
Overview
Diagnostic and treatment delays contribute substantially to disparities in cancer morbidity and mortality between low- and middle- income countries (LMICs) and high-income countries. Individuals present with advanced stage disease resulting in minimal chance for cure or long-term survival. The Potlako project will implement and evaluate a multifaceted intervention to test the hypothesis that a package of enhanced coordination of care including an electronic messaging, transportation support, and training targeted at generalist clinicians at primary and secondary level facilities, can reduce time to diagnosis and stage at diagnosis for HIV-infected individuals with cancer.
Full Title of Study: “Potlako: A Programmatic Multi-facility Level Intervention to Improve Access to Timely Oncology Care in Botswana”
Study Type
- Study Type: Interventional
- Study Design
- Allocation: Non-Randomized
- Intervention Model: Parallel Assignment
- Primary Purpose: Health Services Research
- Masking: None (Open Label)
- Study Primary Completion Date: July 21, 2020
Interventions
- Other: Potlako intervention
- Multicomponent intervention including: provider training on early detection and diagnostic approaches to cancer patient education on importance of obtaining timely cancer diagnosis provision of a patient navigator to facilitate diagnosis and entry into care provision of transportation support to vulnerable patients
Arms, Groups and Cohorts
- Experimental: Kweneng East District
- Patient presenting with possible cancer symptoms/sign to a clinic or hospital in Kweneng East District during study period.
- No Intervention: All other districts
- Patient presenting with possible cancer symptoms/sign to a clinic or hospital in all other districts of Botswana (or Kweneng East prior to implementation of intervention).
Clinical Trial Outcome Measures
Primary Measures
- Cancer stage
- Time Frame: 1 day visit
- Time from initial clinic visit with cancer symptom/sign to entry into oncology care
- Time Frame: 1 day visit
Participating in This Clinical Trial
Inclusion Criteria
- Citizen of Botswana – Suspected or diagnosed cancer Exclusion Criteria:
- Involuntary incarceration
Gender Eligibility: All
Minimum Age: 18 Years
Maximum Age: N/A
Are Healthy Volunteers Accepted: Accepts Healthy Volunteers
Investigator Details
- Lead Sponsor
- Harvard School of Public Health (HSPH)
- Collaborator
- Brigham and Women’s Hospital
- Provider of Information About this Clinical Study
- Principal Investigator: Scott Dryden-Peterson, Assistant Professor, Research Affiliate – Harvard School of Public Health (HSPH)
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.